The focus here centers on methods aimed at elevating levels of a specific glycoprotein hormone. This hormone, produced by granulosa cells in ovarian follicles, serves as an indicator of ovarian reserve the quantity of remaining oocytes. Its concentration in the blood is often assessed to evaluate a womans reproductive potential and predict her response to fertility treatments.
Maintaining or improving this hormonal marker is of significant interest to individuals experiencing diminished ovarian reserve, those planning to delay childbearing, or those undergoing fertility treatments. Historically, interventions targeting this hormone were limited, emphasizing lifestyle modifications and supportive therapies. However, ongoing research explores potential pharmaceutical and dietary strategies that may influence its production.